Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors

Background Approximately 35% of patients with midgut neuroendocrine tumors (MNET) present with distant metastases. Although successful resection of these metastatic foci improves overall survival (OS), the role of primary tumor resection (PTR) in patients with unresectable metastatic disease is uncl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2020-08, Vol.27 (8), p.2795-2803
Hauptverfasser:	Polcz, Monica, Schlegel, Cameron, Edwards, Gretchen C., Wang, Fei, Tan, Marcus, Kiernan, Colleen, Solórzano, Carmen C., Idrees, Kamran, Parikh, Alexander, Bailey, Christina E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Gastrointestinal Oncology Humans Intestinal Neoplasms - surgery Medicine Medicine & Public Health Metastases Metastasis Midgut Mortality Neuroendocrine tumors Neuroendocrine Tumors - surgery Oncology Proportional Hazards Models Retrospective Studies Small intestine Stomach Neoplasms - surgery Surgery Surgical Oncology Survival Survival analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!